Vascular complications in patients with hyperhomocysteinemia
|
|
- Kristopher Randolph Harmon
- 5 years ago
- Views:
Transcription
1 Relation of a Common Methylenetetrahydrofolate Reductase Mutation and Plasma Homocysteine With Intimal Hyperplasia After Coronary Stenting Tai Kosokabe, MD; Kenji Okumura, MD; Takahito Sone, MD; Junichiro Kondo, MD; Hideyuki Tsuboi, MD; Hiroaki Mukawa, MD; Takahito Tomida, MD; Tomomichi Suzuki, MD; Hiroki Kamiya, MD; Hideo Matsui, MD; Tetsuo Hayakawa, MD Background Hyperhomocysteinemia has been identified as an independent risk factor for coronary artery disease. Recent studies have shown that a common mutation (nucleotide 677 C3 T) in the methylenetetrahydrofolate reductase (MTHFR) gene may contribute to mild hyperhomocysteinemia and, therefore, to the incidence of coronary artery disease. No information exists, however, regarding the association between the mutation of the MTHFR gene or plasma homocysteine levels and morphological analysis of coronary atherosclerosis using intravascular ultrasound. Methods and Results To examine the potential influence of and homocysteine on coronary arteries morphologically, we screened 62 patients with 65 lesions that were treated with 93 Palmaz-Schatz stents. The plasma homocysteine levels in the patients with the TT genotype were not significantly higher than those in the patients with non-tt (CC CT) genotypes ( versus mmol/l, P 0.16). Angiographic analysis showed that the percent diameter stenosis in the patients with the TT genotype was significantly greater than that in those with non-tt genotypes ( % versus %, P 0.015). Intravascular ultrasound analysis showed that the TT genotype was significantly associated with greater intimal hyperplasia area ( versus mm 2, P 0.001). In multiple stepwise regression analysis, the number of the T alleles was the only independent predictor of intimal hyperplasia after intervention (r , P 0.004). Conclusions The homozygous mutant genotype of the MTHFR gene may increase the risk of in-stent restenosis more than does the normal homozygous or heterozygous genotype. (Circulation. 2001;103: ) Key Words: angiography genes restenosis stents ultrasonics Vascular complications in patients with hyperhomocysteinemia are well known. To date, numerous studies have described the relationship between plasma homocysteine levels and vascular disease, including coronary atherosclerosis. Except for a few studies, 1,2 almost all published data have indicated that hyperhomocysteinemia is a significant independent risk factor for the development of coronary artery disease (CAD) and venous thrombosis. 3 6 Plasma homocysteine concentrations are influenced by many environmental and genetic factors. Plasma homocysteine levels also increase with age. 7 In general, men have higher plasma homocysteine levels than women. 7 Although the mechanism is unclear, renal function elevates plasma homocysteine levels. 8 Deficiencies in vitamins B 6 and B 12 and folate, which are essential coenzymes in homocysteine metabolism, elevate plasma homocysteine levels. 9,10 Several studies 11,12 have indicated that the disease itself may elevate plasma homocysteine concentrations. Egerton et al 11 reported that an analysis of samples obtained at the time of a myocardial infarction and up to 180 days later indicated an increase in homocysteine concentration by 27%. Lindgren et al 12 reported that samples collected within 2 days of a stroke and up to 645 days later exhibited a rise in homocysteine concentration by 27%. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate, the methyl donor for the remethylation of homocysteine to methionine. Kang et al 13 reported that up to 5% of the general population has an inherited thermolabile form of MTHFR, one that is associated with reduced activity of the enzyme. Frosst et al 14 identified a mutation (nucleotide 677 C to T; ie, alanine to valine substitution in the enzyme) in the MTHFR gene that correlated with thermolability and reduced MTHFR activity. They concluded that individuals with homozygosity for the mutation have significantly elevated plasma homocysteine levels. These findings suggest that this homozygous mutant gene may be a risk factor for Received September 6, 2000; revision received January 24, 2001; accepted January 26, From Internal Medicine II, Nagoya University School of Medicine (T.K., K.O., T.T., T. Suzuki, H.K., H. Matsui, T.H.), Nagoya, Japan; and Department of Cardiology (T. Sone, J.K., H.T., H. Mukawa), Ogaki Municipal Hospital, Ogaki, Japan. Reprint requests to Kenji Okumura, MD, Internal Medicine II, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya , Japan. kenji@med.nagoya-u.ac.jp 2001 American Heart Association, Inc. Circulation is available at
2 Kosokabe et al MTHFR Gene and Homocysteine Effects on Restenosis 2049 CAD through mild hyperhomocysteinemia. Numerous studies have been conducted to examine the relationship between this mutation and the incidence of CAD. Although some studies reported that the mutation was associated with an increased risk of CAD, 15,16 others reported that the mutation were not associated with increased risk of CAD. 17,18 However, few morphological analyses of coronary atherosclerosis using intravascular ultrasound (IVUS) have been reported. The purpose of this study was to analyze morphologically whether the MTHFR 677 C to T mutation correlates with an increased risk of in-stent restenosis, as assessed by IVUS analysis. Methods Patient and Lesion Population From September 1997 to December 1998, 64 patients were enrolled in this study. The inclusion criterion for patients was successful stent implantation with a proximal reference diameter of at least 3.0 mm. We analyzed 65 lesions (left anterior descending, 35; left circumflex, 9; and right coronary artery, 21) in 62 patients (aged 64 9 years; 49 men). The exclusion criterion was a serum creatinine concentration 2.0 mg/dl. Written, informed consent was obtained from all study participants before intervention. All subjects received 200 mg of ticlopidine and 160 mg of aspirin per day after coronary intervention, and no significant difference existed between the groups in terms of frequency of use of other cardiac medication. Follow-up angiography at 6 months was part of the study protocol. During the follow-up period, 3 patients received follow-up angiography because of recurrent symptoms. These results were used as the 6-month results. IVUS analysis was available in 45 lesions (69%). At the time of stent implantation, 9 patients presented with acute myocardial infarction and 15 with unstable angina. Forty-five lesions were treated with a single Palmaz-Schatz stent, 12 were treated with 2 stents, and 8 were treated with 3 stents. Of all stents, 57 were 3.0 mm, 27 were 3.5 mm, and 9 were 4.0 mm. Palmaz-Schatz stents were implanted according to standard protocols. 19,20 IVUS-guided coronary angioplasty and stenting were performed in all patients. All stents were implanted using highpressure adjunct balloon angioplasty ( atm) to achieve the targeted stent expansion. The targeted stent expansion was a minimal area 80% of the average of the proximal and distal reference lumen areas by IVUS, as well as complete stent-vessel wall apposition. Angiographic Analysis Angiography was performed after the administration of 0.2 mg of intracoronary nitroglycerin. All films of cineangiograms were analyzed by an independent, experienced core angiographic laboratory without knowledge of the results of ultrasound analysis. Using an automated edge detection algorithm (QCA-CMS System, MEDIS Inc), the minimum lumen diameter, reference diameter, and percent diameter stenosis (%DS) were measured from multiple projections; the results in the worst view were recorded. User-defined reference segments were selected as the mean of 10-mm-long segments proximal and distal to the lesion. Angiographic restenosis was defined as a DS 50%. Late loss was calculated as postintervention minus follow-up minimum lumen diameter. The late loss index was calculated by dividing the late loss by the early gain. IVUS Image Acquisition and Analysis IVUS imaging was performed using a 30-MHz mechanical ultrasound transducer (Ultra Cross TM 3.2, Boston Scientific SCIMED). The transducer was withdrawn within the stationary imaging sheath at a speed of 0.5 mm/s using a motorized transducer pullback device after the administration of 0.2 mg of intracoronary nitroglycerin. Using computerized planimetry, quantitative IVUS analysis was performed by a single individual who was blinded to angiographic and genetic results. Validation of cross-sectional measurements by IVUS has been reported previously External elastic membrane, stent, and lumen areas were measured. In addition to the analysis of the narrowest cross-section, proximal and distal reference segments were analyzed. A reference segment was defined as the most normal looking cross-sections within a 10-mm segment proximal or distal to the stent that did not crossing any large side branches. Reference segment areas were calculated as the mean value of the proximal and distal reference areas. Late lumen loss was calculated as postintervention lumen area minus follow-up lumen area. Intimal hyperplasia (IH) area was calculated as stent minus lumen area at follow-up. Relative IH was calculated as IH area divided by follow-up stent area. Plaque area was calculated as external elastic membrane area minus lumen area, because ultrasound cannot accurately measure media thickness. 24 Measurement of Plasma Homocysteine Levels and Genetic Analysis Plasma homocysteine levels were measured 3 months after coronary intervention. Fasting venous blood was drawn because plasma homocysteine levels have been shown to be influenced by meals. 25 Plasma homocysteine levels were determined as total homocysteine by high-performance liquid chromatography with fluorescence detection, as previously described. 26 Genomic DNA was isolated from nucleated blood cells using a phenol chloroform method. Identification of the C to T transition at nucleotide 677 was determined using the method of Frosst et al. 14 Because the C to T mutation at nucleotide 677 produces the Hinf I digestion site, the polymerase chain reaction product (198 bp) derived from the mutant gene is digested into 175-bp and 23-bp fragments by Hinf I. Statistics Statistical analysis was performed using StatView 5.0 (SAS Institute). Continuous variables are presented as mean SD, and categoric variables are presented as frequencies. Because our subject group was small and no significant differences existed in any variables between the wild-type (CC) and heterozygous genotype (CT), we established 2 genotype groups: the mutant homozygote (TT) and the others (non-tt: CC CT). Continuous variables were compared using Student s t test. The categoric data were compared using 2 analysis. Pearson product-moment correlation coefficients (r) were computed to identify the variables that were significantly associated with follow-up %DS, as measured by angiography, and IH area, as measured by IVUS. Forward stepwise multiple regression analysis was performed to examine significant contributions of the variables to the prediction of follow-up %DS and IH area. P 0.05 was considered statistically significant. Results Plasma Homocysteine Concentration and MTHFR Genotypes The allele frequency of the T mutation in the 62 patients was The distribution of the 3 genotypes was as follows: homozygous normal (CC) genotype, 30.7%; heterozygous (CT) genotype, 41.9%; and homozygous mutant (TT) genotype, 27.4%. These genotypic distributions were similar to those described previously in patients with CAD. 27 Clinical characteristics of all patients with each genotype are shown in Table 1. The plasma homocysteine concentration in the patients with the TT genotype was higher than that in those with non-tt genotypes ( versus mmol/l, P 0.16), but the difference was not statistically significant. No significant difference existed between the patients with TT and non-tt genotypes for any variables examined, including age, sex, and creatinine, that influenced plasma homocysteine levels.
3 2050 Circulation April 24, 2001 TABLE 1. Patient Characteristics in Each MTHFR Genotype CC (n 19) CT (n 26) TT (n 17) non-tt (n 45) P * Sex, male/female 15/4 20/6 14/3 35/ Age, y Body mass index, kg/m Acute myocardial infarction, n Unstable angina, n Smoker/nonsmoker, n 4/15 9/17 6/11 13/ Blood pressure, mm Hg Systolic Diastolic Glucose, mg/dl Total cholesterol, mg/dl Triglyceride, mg/dl Creatinine, mg/dl Homocysteine, mol/l Data are presented as mean SD or No. of patients. Angiographic Results Representative angiograms and IVUS images are shown in the Figure. Lesion characteristics are shown in Table 2. No significant differences in lesion site, lesion type, lesion length, number of stents, stent size, and maximal inflation pressure existed between the patients with the TT and non-tt genotypes. In addition, no significant differences existed in reference diameters or minimum lumen diameters before intervention, after intervention, and at follow-up between the TT and non-tt groups (Table 3). There was no significant difference in %DS before intervention or after intervention; however, %DS in the patients with the TT genotype was Representative angiograms (A and B) and IVUS images (C and D) of patient with TT genotype and right coronary artery lesions. Follow-up DS was 55.4% by quantitative coronary angiographic analysis (B). IVUS images (D) revealed a large amount of intimal hyperplasia at follow-up (IH area, 9.6 mm 2 ; relative IH, 82.8%).
4 Kosokabe et al MTHFR Gene and Homocysteine Effects on Restenosis 2051 TABLE 2. Lesion Characteristics Among Each MTHFR Genotype CC (n 20) CT (n 28) TT (n 17) non-tt (n 48) P * Intervals, days Lesion site, n RCA LAD LCX Lesion type (AHA/ACC), n A B B C Ostial/nonostial, n 3/17 1/27 1/16 4/ No. of stents Stent size, mm Lesion length, mm Inflation pressure, atm Data are presented as mean SD or No. of patients. RCA indicates right coronary artery; LAD, left anterior descending artery; and LCX, left circumflex artery. significantly greater than that in those with the non-tt genotypes ( % versus %, P 0.015) at follow-up. The late loss was mm in the TT group and mm in the non-tt group (P NS). The late loss index and restenosis rate were higher in the patients with the TT genotype than in those with the non-tt genotypes (59.6% versus 46.7% and 29.4% versus 12.5%, respectively), but the differences were not statistically significant. TABLE 3. Angiographic Characteristics in Each MTHFR Genotype CC (n 20) Serial IVUS Results IVUS variables were available in 45 lesions after intervention and at follow-up. Table 4 summarizes IVUS results in s. The subjects with the TT genotype had greater external elastic membrane and plaque areas in the reference segment after intervention (both P 0.016) but not at follow-up. At the narrowest cross-section, lumen area decreased from to mm 2 in the TT CT (n 28) TT (n 17) non-tt (n 48) P * Before intervention Reference diameter, mm MLD, mm DS, % After intervention Reference diameter, mm MLD, mm DS, % Follow-up Reference diameter, mm MLD, mm DS, % Late loss, mm Late loss index, % Restenosis rate, % Data are presented as mean SD. MLD indicates minimum lumen diameter.
5 2052 Circulation April 24, 2001 TABLE 4. IVUS Variables Among Each MTHFR Genotype CC (n 13) CT (n 21) TT (n 11) non-tt (n 34) P After intervention Reference EEM area, mm Lumen area, mm Plaque area, mm Narrowest site Lumen area, mm Follow-up Reference EEM area, mm Lumen area, mm Plaque area, mm Narrowest site Stent area, mm Lumen area, mm Late lumen loss, mm IH area, mm Relative IH, % Data are presented as mean SD. EEM indicates external elastic membrane. group and from to mm 2 in the non-tt group, indicating no significant difference between the 2 groups regarding the lumen area at follow-up. However, the late lumen loss in those with the TT genotype was significantly greater than that in those with non-tt genotypes. ( versus mm 2, P 0.002). IH area in those with TT genotypes was also significantly greater than that in those with non-tt genotypes ( versus mm 2, P 0.001). Univariate and Stepwise Multivariate Analysis of Determinant of Increased Follow-Up %DS and IH Area Univariate analysis using the Pearson correlation coefficients was performed to determine which variables were associated with follow-up %DS and IH area (Table 5). The number of T alleles was significantly associated with IH area by IVUS analysis and had a tendency to increase follow-up %DS (r 0.24, P 0.053), although plasma homocysteine levels were not associated with follow-up %DS or IH area. In terms of stepwise multiple regression analysis, the number of T alleles (r , P 0.004) was the only predictor of IH area (data not shown). Discussion Although stent implantation is expected to decrease restenosis after angioplasty and a high primary success rate has been obtained, the late restenosis rate still limits the long-term benefit of this procedure. 28 A number of studies have attempted to determine the clinical, angiographic, and genetic features that predict restenosis. Many variables have been suggested as candidates associated with restenosis, but only a few genetic predispositions have been reported previously. 29,30 In this study, a harmful effect of homozygosity for the mutation of the MTHFR gene was revealed after stent implantation, as determined using both quantitative coronary angiography and IVUS imaging. Interestingly, the number of T alleles was the only independent predictor for IH area by IVUS analysis after coronary stenting. Quantitative assessment with IVUS may be superior to angiography for the evaluation of coronary artery stenosis because it provides more detailed information from tomographic views of coronary arteries than does angiography. Numerous studies have reported that homozygosity for the mutation was associated with mild hyperhomocysteinemia In this study, however, we failed to find a significant correlation between TABLE 5. Univariate Analysis of Predictors for Follow-Up %DS and IH Area Variables Follow-up %DS IH area r P r P Homocysteine Number of T alleles Lesion length Number of stents Inflation pressure Post-reference plaque area Post-reference lumen area Post-lumen area at narrowest site
6 Kosokabe et al MTHFR Gene and Homocysteine Effects on Restenosis 2053 plasma homocysteine levels and s. One reason for this may be the small population of patients enrolled. Another reason for the lack of relationship may be that plasma homocysteine levels are also determined by factors other than MTHFR, as mentioned above. Postprandial homocysteine levels may be higher in individuals with the homozygous mutant genotype than in those with the normal genotype. Therefore, despite a lack of a sufficient relationship between the to fasting homocysteine levels, hyperhomocysteinemia must be due, in part, to the mutation of the MTHFR gene. The hypothesis that the elevation of plasma homocysteine levels is a risk factor for CAD is of considerable interest. However, few morphological studies have focused on the relationship between hyperhomocysteinemia and coronary atherosclerosis. In our study, the plaque area in reference segments was correlated with plasma homocysteine levels after intervention (n 58, r 0.38, P 0.004; data not shown). In addition, we observed greater plaque areas in reference segments in the patients with mutant homozygosity for MTHFR than in those with the normal homozygous and heterozygous genotypes combined. These findings are consistent with the previous reports describing an association between hyperhomocysteinemia and increased incidence of CAD, 3 5 although a significant relationship between follow-up %DS to plasma homocysteine levels was not found in this study. The mechanisms by which hyperhomocysteinemia promotes the development of atherosclerosis are not fully understood. It has been shown that a short-term increase in homocysteine concentration induced by an oral methionine load leads to endothelial dysfunction, probably resulting from oxidative effects, including the generation of superoxide anion radicals and hydrogen peroxide. 31 The resultant endothelial dysfunction, such as an impairment of the release and/or effects of nitric oxide, may then contribute to the progression of atherosclerosis. Other putative mechanisms include smooth muscle proliferation, extracellular matrix modification, lipoprotein oxidation, cytotoxicity, and effects on platelets and coagulation. 32 Recent studies using IVUS have suggested that in-stent restenosis and late lumen loss were the results of IH caused by smooth muscle cell migration and matrix formation because the Palmaz-Schatz stent prevents remodeling processes such as elastic vessel recoil. 22 In this study, the stent areas of the patients with mutant homozygosity for the MTHFR gene were greater to some extent than those of the other patients. Although only a weak correlation existed between IH area and stent area, IH thickness at follow-up was independent of stent size, as assessed by IVUS analysis. 33 Therefore, stent area does not seem to be a confounding factor. Relative IH area, which may account for differences in IH between the 2 groups, was significantly higher in the mutant homozygote group than in the other groups. In stepwise multivariate regression, the only independent contributor predicting IH area was the number of T alleles, not plasma homocysteine levels. These findings may suggest that the effect of the increasing IH of the mutant homozygosity for the MTHFR gene was due to unknown factors, such as the greater plaque burden of this genotype before intervention, rather than the effect of hyperhomocysteinemia itself. However, our results suggest homocysteine-lowering therapy, such as folate supplementation, 34 in the patients with mutant homozygosity for MTHFR gene may prevent the development of restenosis after stent implantation. Study Limitations The number of patients in the present study was fairly small, and larger studies will be needed to confirm our findings. Only Palmaz-Schatz stents were included; the frequency and magnitude of these findings in regard to other stents are unknown. The narrowest site evaluated by angiography was different from that evaluated by IVUS. Although IVUSguided coronary angioplasty was performed in all subjects, we did not perform quantitative evaluation of IVUS before intervention. Therefore, the plaque burden at the narrowest site before intervention was undetermined. During this period, we measured plasma homocysteine concentrations only once at 3 months after intervention. Because homocysteine concentrations fluctuate according to the state of the disease, more frequent measurements of plasma homocysteine concentrations may provide more detailed information. Conclusions The present study was the first morphological analysis of the association between the and in-stent restenosis using IVUS. The mutant homozygote of the MTHFR gene might increase the risk of in-stent restenosis more than does the normal homozygous or heterozygous genotype. The mechanism may be attributed to the facilitative effect of mild hyperhomocysteinemia on the development of coronary atherosclerosis in subjects with the mutant genotype of the MTHFR gene. References 1. Alfthan G, Pekkanen J, Jauhiainen M, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to athelosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994; 106: Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the atherosclerosis risk in communities study. Circulation. 1993;87: Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324: Genest JJ, McNamara JR, Salem DN, et al. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990;16: Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarctions in US physicians. JAMA. 1992;268: Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274: Kang SS, Wong PWK, Cook HY, et al. Protein-bound homocyst(e)ine: a possible risk factor for coronary artery disease. J Clin Invest. 1986;77: Chauveau P, Chadefaux B, Coude M, et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int. 1993; 43:S72 S Kang S-S, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36: Ubbink JB, Vermaak WJH, van der Merwe A, et al. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47 53.
7 2054 Circulation April 24, Egerton W, Silberberg J, Crooks R, et al. Serial measures of plasma homocyst(ei)ne after acute myocardial infarction. Am J Cardiol. 1996; 77: Lindgren A, Brattstršm L, Norrving B, et al. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke. 1995;26: Kang SS, Wong PWK, Susmano A, et al. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48: Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10: Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5,10- methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95: Christensen B, Frosst P, Lussier-Cacan S, et al. Correlation of a common mutation in the Methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17: Anderson JL, King GJ, Thomson MJ, et al. A mutation in the Methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol. 1997;30: Wilcken DEL, Wang XL, Sim AS, et al. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C 677 T mutation. Arterioscler Thromb Vasc Biol. 1996;16: Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91: Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation. 1991;83: Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94: Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94: Nishimura RA, Edwards WD, Warnes CA, et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol. 1990;16: Mallery JA, Tobis JM, Griffith J, et al. Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J. 1990;119: Guttormsen AB, Schneede J, Fiskerstrand T, et al. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr. 1994;124: Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422: Mager A, Lalezari S, Shohat T, et al. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation. 1999;100: Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331: van Bockxmeer FM, Mamotte CDS, Gibbons FA, et al. Angiotensinconverting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995;92: Ribichini F, Steffenino G, Dellavalle A, et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation. 1998;97: Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996;98: Bellamy MF, McDowell IFW. Putative mechanisms for vascular damage by homocysteine. J Inher Metab Dis. 1996;20: Hoffmann R, Mintz GS, Pichard AD, et al. Intimal hyperplasia thickness at follow-up is independent of stent size: a serial intravascular ultrasound study. Am J Cardiol. 1998;82: Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7 9.
Angiographic and Intravascular Ultrasound Predictors of In-Stent Restenosis
1630 JACC Vol. 32, No. 6 Angiographic and Intravascular Ultrasound Predictors of In-Stent Restenosis SHUNJI KASAOKA, MD, JONATHAN M. TOBIS, MD, FACC, TATSURO AKIYAMA, MD,* BERNHARD REIMERS, MD,* CARLO
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationMETHYLENETETRAHYDROFOLATE REDUCTASE GENE AMONG THE JAPANESE
Jpn J Human Genet 41, 247 251, 1996 Short Communication A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE GENE AMONG THE JAPANESE POPULATION Hisahide NISHIO, L* Myeong Jin LEE, ~ Motoko FuJlI, 1
More informationMethylene Tetrahydrofolate Reductase Gene and Coronary Artery Disease
Methylene Tetrahydrofolate Reductase Gene and Coronary Artery Disease M. P. Iqbal,P. M. Frossard ( Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi. ) Hyperhomocysteinemia
More informationJournal of the American College of Cardiology Vol. 34, No. 1, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 34, No. 1, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00151-5 Mechanisms
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationJournal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.
Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009
More informationPCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
More informationOne third to one half of the variation in vascular disease
Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease Jeffrey L. Anderson, MD; Joseph
More informationin a population with low plasma
518 Cardiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey S L Tokgözoğlu E Atalar K Aytemir N Özer K Övünç S Kes Paediatric Genetics, Hacettepe University Faculty of Medicine M Alikaşifoğlu
More informationValidation of the In Vivo Intravascular Ultrasound Measurement of In-Stent Neointimal Hyperplasia Volumes
794 JACC Vol. 32, No. 3 Validation of the In Vivo Intravascular Ultrasound Measurement of In-Stent Neointimal Hyperplasia Volumes ROXANA MEHRAN, MD, GARY S. MINTZ, MD, FACC, MUN K. HONG, MD, FACC, FERMIN
More informationJournal of the American College of Cardiology Vol. 34, No. 4, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 34, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00324-1 Final
More informationClinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India
Human Journals Research Article September 2018 Vol.:13, Issue:2 All rights are reserved by Alpana Saxena et al. Clinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India
More informationOriginal paper. Introduction. Material and methods. Aim
Original paper Relation between coronary plaque calcium deposits as described by computed tomography coronary angiography and acute results of stent deployment as assessed by intravascular ultrasound Jerzy
More informationAssociation between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease
Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease ROXANA BUZAŞ, CORINA ŞERBAN, IOANA SUCEAVA, DANIEL LIGHEZAN University
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationINTRODUCTION. ORIGINAL ARTICLE DOI: /kjim
ORIGINAL ARTICLE DOI: 10.3904/kjim.2010.25.4.356 Usual Dose of Simvastatin Does Not Inhibit Plaque Progression and Lumen Loss at the Peri-Stent Reference Segments after Bare-Metal Stent Implantation: A
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More informationPCI for Long Coronary Lesion
PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2
More informationThe deployment of endovascular stents offers a significant
Homocysteine Status and Polymorphisms of Methylenetetrahydrofolate Reductase Are Not Associated With Restenosis After Stenting in Coronary Arteries Werner Koch, Gjin Ndrepepa, Julinda Mehilli, Siegmund
More informationSmall Stent Size and Intimal Hyperplasia Contribute to Restenosis: A Volumetric Intravascular Ultrasound Analysis
720 JACC Vol. 26, No. 3 Small Stent Size and Intimal Hyperplasia Contribute to Restenosis: A Volumetric Intravascular Ultrasound Analysis GASTON R. DUSSAILLANT, MD, GARY S. MINTZ, MD, FACC, AUGUSTO KENNETH
More informationOBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS
Journal of the American College of Cardiology Vol. 37, No. 5, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01162-7 Long-Term
More informationJournal of the American College of Cardiology Vol. 39, No. 8, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 39, No. 8, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01774-6
More informationThe Influence of Diabetes Mellitus on Acute and Late Clinical Outcomes Following Coronary Stent Implantation
584 JACC Vol. 32, No. 3 The Influence of Diabetes Mellitus on Acute and Late Clinical Outcomes Following Coronary Stent Implantation ALEXANDRE ABIZAID, MD, RAN KORNOWSKI, MD, GARY S. MINTZ, MD, FACC, MUN
More informationSirolimus-Eluting Stents for Treatment of In-Stent Restenosis
Clinical Investigation Alfonso Medina, MD José Suárez de Lezo, MD Manuel Pan, MD Antonio Delgado, MD José Segura, MD Djordje Pavlovic, MD Francisco Melián, MD Miguel Romero, MD Federico Segura, MD Enrique
More informationIntracoronary Serum Smooth Muscle Myosin Heavy Chain Levels Following PTCA may Predict Restenosis
Clinical Studies Intracoronary Serum Smooth Muscle Myosin Heavy Chain Levels Following PTCA may Predict Restenosis Yasuhiro TSUCHIO,MD,ShigetoNAITO, MD, Akihiko NOGAMI,MD, Hiroshi HOSHIZAKI, MD, ShigeruOSHIMA,
More informationRelationship Between Cardiovascular Risk Factors and Atherosclerotic Disease Burden Measured by Intravascular Ultrasound
Journal of the American College of Cardiology Vol. 47, No. 10, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.12.058
More informationThe Site of Plaque Rupture in Native Coronary Arteries
Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.067
More informationHyperhomocysteinemia is known to be an. Methylenetetrahydrofolate Reductase Gene Polymorphism. Relation to Blood Pressure and Cerebrovascular Disease
AJH 1998;11:1019 1023 BRIEF COMMUNICATIONS Methylenetetrahydrofolate Reductase Gene Polymorphism Relation to Blood Pressure and Cerebrovascular Disease Yukiko Nakata, Tomohiro Katsuya, Seiju Takami, Noriyuki
More informationAdjunctive Stent Implantation Following Directional Coronary Atherectomy in Patients With Coronary Artery Disease
JACC Vol. 32, No. 7 December 1998:1855 60 1855 Adjunctive Stent Implantation Following Directional Coronary Atherectomy in Patients With Coronary Artery Disease EZIO BRAMUCCI, MD,* LUIGI ANGOLI, MD,* PIERA
More informationIntracoronary stents reduce restenosis compared with balloon
Treatment of In-Stent Restenosis With Excimer Laser Coronary Angioplasty Versus Rotational Atherectomy Comparative Mechanisms and Results Roxana Mehran, MD; George Dangas, MD, PhD; Gary S. Mintz, MD; Ron
More informationDeclaration of conflict of interest. Nothing to disclose
Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han
More informationFor Personal Use. Copyright HMP 2013
Case Report J INVASIVE CARDIOL 2013;25(2):E39-E41 A Case With Successful Retrograde Stent Delivery via AC Branch for Tortuous Right Coronary Artery Yoshiki Uehara, MD, PhD, Mitsuyuki Shimizu, MD, PhD,
More informationIVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation
IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation SURE Trial: Restenosis in non-stented lesions Average of the two image slices with the smallest
More informationSide Branch Occlusion
Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion
More informationBasics of Angiographic Interpretation Analysis of Angiography
Basics of Angiographic Interpretation Analysis of Angiography Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Seoul, Korea What made us nervous Supervisors Stent Contrast
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationJournal of the American College of Cardiology Vol. 35, No. 2, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 2, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00567-7 Greater
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationIntravascular Ultrasound
May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient
More informationBiodegradable Stents An update and work-in
Biodegradable Stents An update and work-in in-progress Department of Cardiology, Hideo Tamai, M.D. Metallic stents... Background induce a varing degree of thrombogenesis eg, subacute thrombosis in complex
More informationEBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb
EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain) Provisional
More informationInfluence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence
More informationPredictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease
Original Article Acta Cardiol Sin 2009;25:1 6 Coronary Artery Disease Predictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease Yung-Lung Chen,
More informationBetween Coronary Angiography and Fractional Flow Reserve
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional
More informationCurrent Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationResults of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies
Intracoronary Radiation Therapy Improves the Clinical and Angiographic Outcomes of Diffuse In-Stent Restenotic Lesions Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions
More informationFFR and intravascular imaging, which of which?
FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment
More informationPrevention of Coronary Stent Thrombosis and Restenosis
Prevention of Coronary Stent Thrombosis and Restenosis Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea 9/12/03 Coronary
More informationMechanisms and Predictors of Carotid Artery Stent Restenosis A Serial Intravascular Ultrasound Study
Journal of the American College of Cardiology Vol. 47, No. 12, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.01.076
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationSafety and Efficacy of Coronary Stent Implantation. Acute and Six Month Outcomes of 1,126 Consecutive Patients Treated in 1996 and 1997
Original Article Safety and Efficacy of Coronary Stent Implantation. Acute and Six Month Outcomes of 1,126 Consecutive Patients Treated in 1996 and 1997 Luiz Alberto Mattos, Ibraim Pinto, Alexandre Abizaid,
More informationSerial Volumetric (Three-Dimensional) Intravascular Ultrasound Analysis of Restenosis After Directional Coronary Atherectomy
1874 Serial Volumetric (Three-Dimensional) Intravascular Ultrasound Analysis of Restenosis After Directional Coronary Atherectomy EVELYN A. DE VREY, MD,* GARY S. MINTZ, MD, FACC,* CLEMENS VON BIRGELEN,
More informationFFR and IVUS Guided DES Implantation in Long Diffuse Lesions
FFR and IVUS Guided DES Implantation in Long Diffuse Lesions Can We Reach Optimal DES Expansion With Conventional Stent Delivery System in Long Diffuse Lesion? Seung-Jea Tahk, MD., PhD. Ajou University
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationIn-stent Restenosis: the Achille's Heel of SFA Stenting
In-stent Restenosis: the Achille's Heel of SFA Stenting Yann Gouëffic, MD, PhD Department of Vascular Surgery University Hospital of Nantes, France «Unresolved problems of SFA stenting» In-stent restenosis
More informationand Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine
PPAR- Agonist and In-Stent Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine Peroxisome Proliferator- activated Receptors (PPAR) Lipid-activated transcription factors : => regulating
More informationJournal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01458-9 Cutting
More informationRationale and algorithm for below-the-knee acute gain optimization
Leipzig, 01 Feb. 2018 Rationale and algorithm for below-the-knee acute gain optimization Flavio Airoldi, MD Flavio Airoldi Multimedica IRCCS Milan ITALY flavio.airoldi@multimedica.it Rationale Restenosis
More informationMorphological changes after percutaneous transluminal coronary angioplasty of unstable plaques
European Heart Journal (1996) 17, 1554-1559 orphological changes after percutaneous transluminal coronary angioplasty of unstable plaques Insights from serial angioscopic follow-up C. Bauters, J.-. Lablanche,
More informationEvolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands
Evolution In Interventional Cardiology Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands 25 November 2010 Coronary Atherosclerosis Timeline in interventional cardiology Indications for
More informationSafety and Efficacy of Angioplasty with Intracoronary Stenting in Patients with Unstable Coronary Syndromes. Comparison with Stable Coronary Syndromes
Original Article Safety and Efficacy of Angioplasty with Intracoronary Stenting in Patients with Unstable Coronary Syndromes. Comparison with Stable Coronary Syndromes Luís C. L. Correia, José Carlos Brito,
More informationIntegrated Use of IVUS and FFR for LM Stenting
Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher
More informationHyperhomocystinemia in patients with coronary artery disease
Brazilian Journal of Medical and Biological Research (2006) 39: 455-463 Hyperhomocystinemia and coronary disease ISSN 0100-879X 455 Hyperhomocystinemia in patients with coronary artery disease J.R. Faria-Neto
More informationThe Use of Intravascular Ultrasound and Spot Stenting for the Treatment of Long Lesions and Small Vessels
IAGS 1998 Proceedings The Use of Intravascular Ultrasound and Spot Stenting for the Treatment of Long Lesions and Small Vessels Issam Moussa, MD, Joseph De Gregorio, MD, Carlo Di Mario, PhD, MD, Antonio
More informationPrimary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone
Journal of Cardiology (2008) 51, 18 24 Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone Hajime Fujimoto, Susumu Tao, Tomotaka Dohi, Sachiko Ito, Jun
More informationEvaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013
Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationCatheter Interventions for Kawasaki Disease: Current Concepts and Future Directions
REVIEW DOI 10.4070/kcj.2011.41.2.53 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright 2011 The Korean Society of Cardiology Open Access Catheter Interventions for Kawasaki Disease: Current Concepts
More informationMaking the difference with Live Image Guidance
Interventional Cardiology AlluraClarity Making the difference with Live Image Guidance Diagnosis and treatment of coronary artery diseases and atherosclerosis Where/who The First Bethune Hospital of Jilin
More informationInterventional Cardiology
Clinical Investigations Interventional Cardiology Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents Yuji Yoshitomi, MD, PhD, a Shunichi Kojima,
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationA Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience
A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular
More informationInterventional Cardiology
Interventional Cardiology Late Malapposition After Drug-Eluting Implantation An Intravascular Ultrasound Analysis With Long-Term Follow-Up Myeong-Ki Hong, MD, PhD; Gary S. Mintz, MD; Cheol Whan Lee, MD,
More informationA Synergistic Approach to Optimal Stenting Directional Coronary Atherectomy Prior to Coronary Artery Stent Implantation the AtheroLink Registry
Journal of the American College of Cardiology Vol. 36, No. 6, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00967-0 A Synergistic
More informationIVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.
Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center,
More informationOptimal Coronary Balloon Angioplasty With Provisional Stenting Versus Primary Stent (OCBAS)
1351 Optimal Coronary Balloon Angioplasty With Provisional Stenting Versus Primary Stent (OCBAS) Immediate and Long-Term Follow-up Results ALFREDO RODRÍGUEZ, MD, PHD, FACC,* FRANCISCO AYALA, MD,* VICTOR
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationDESolve NX Trial Clinical and Imaging Results
DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or
More informationDECREASED RATE OF CORONARY RESTENOSIS AFTER LOWERING OF PLASMA HOMOCYSTEINE LEVELS
DECREASED RATE OF CORONARY RESTENOSIS AFTER LOWERING OF PLASMA HOMOCYSTEINE LEVELS DECREASED RATE OF CORONARY RESTENOSIS AFTER LOWERING OF PLASMA HOMOCYSTEINE LEVELS GUIDO SCHNYDER, M.D., MARCO ROFFI,
More informationEXPERIMENTAL AND THERAPEUTIC MEDICINE 6: , 2013
840 Identification of independent risk factors for restenosis following bare metal stent implantation: Role of bare metal stents in the era of drug eluting stents CHANG BUM PARK 1 and HOON KI PARK 2 1
More informationSTENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationUsefulness of OCT during coronary intervention
Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization
More informationDISRUPT CAD. Todd J. Brinton, MD Clinical Associate Professor of Medicine Adjunct Professor of Bioengineering Stanford University
DISRUPT CAD A multicenter, prospective, single-arm study of percutaneous Lithoplasty prior to stent implantation in heavily calcified coronary lesions Todd J. Brinton, MD Clinical Associate Professor of
More informationPlaque Removal Prior to Stent Implantation in Native Coronary Arteries: Why? When? and How?
IAGS 1998 Proceedings Plaque Removal Prior to Stent Implantation in Native Coronary Arteries: Why? When? and How? Issam Moussa, MD, Carlo Di Mario, PhD, MD, Antonio Colombo, MD From the Centro Cuore Columbus,
More informationPCI for In-Stent Restenosis. CardioVascular Research Foundation
PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse
More informationInsulin Resistance Is Not Related to Plasma Homocysteine Concentration in Healthy Premenopausal Women
Physiol. Res. 55: 285-29, 26 Insulin Resistance Is Not Related to Plasma Homocysteine Concentration in Healthy Premenopausal Women F. TANRIKULU-KILIÇ, S. BEKPINAR, Y. ÜNLÜÇERÇI, Y. ORHAN 1 Department of
More informationJournal of the American College of Cardiology Vol. 38, No. 1, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 1, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01315-8 Coronary
More informationA Highly Flexible Slotted Tube Stent Design Coated with a-sic:h First Clinical Experiences
40 February 1998 A Highly Flexible Slotted Tube Stent Design Coated with a-sic:h First Clinical Experiences J. KOOLEN, C. HANEKAMP, H. BONNIER 1Catharina Hospital, Eindhoven, Netherlands Summary A new
More informationProgression of coronary atherosclerosis may lead to angina
Regression of Coronary Atherosclerosis by Simvastatin A Serial Intravascular Ultrasound Study Lisette Okkels Jensen, MD, PhD; Per Thayssen, MD, DMSci; Knud Erik Pedersen, MD, DMSci; Steen Stender, MD,
More informationSpotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction An Intravascular Ultrasound Study
Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction An Intravascular Ultrasound Study Shoichi Ehara, MD; Yoshiki Kobayashi, MD; Minoru Yoshiyama, MD; Kenei Shimada,
More informationKey Words Angioplasty Coronary artery disease Revascularization Stent drug eluting stent
J Cardiol 26 Dec; 48 6 : 325 331 3 mm : Initial and Mid-Term Effects of 3 mm Long Sirolimus-Eluting Stents in Patients With Diffuse Long Coronary Lesions: Comparison With Bare Metal Stents Abstract Yosuke
More informationData Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.
1994--4 Vascular Biology Working Group www.vbwg.org c/o Medical Education Consultants, LLC 25 Sylvan Road South, Westport, CT 688 Chairman: Carl J. Pepine, MD Eminent Scholar American Heart Association
More informationHyperhomocysteinemia but Not the C677T Mutation of Methylenetetrahydrofolate Reductase Is an Independent Risk Determinant of Carotid Wall Thickening
Hyperhomocysteinemia but Not the C677T Mutation of Methylenetetrahydrofolate Reductase Is an Independent Risk Determinant of Carotid Wall Thickening The Perth Carotid Ultrasound Disease Assessment Study
More informationIntravascular ultrasound-based analysis of factors affecting minimum lumen area in coronary artery intermediate lesions
Journal of Geriatric Cardiology (2016) 13: 169 174 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Intravascular ultrasound-based analysis of factors affecting minimum lumen area
More informationPlaque Shift vs. Carina Shift Prevalence and Implication
TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan
More informationSolving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System
Volume 1, Issue 1 Case Report Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Robert F. Riley * and Bill Lombardi University of Washington Medical Center, Division
More information